- Home
- KODK vs PSNL Comparison
KODK vs PSNL Comparison
Compare KODK & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KODK | PSNL |
|---|---|---|
| Founded | 1880 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 697.0M | 729.1M |
| IPO Year | 1994 | 2019 |
Fundamental Metrics
Financial Performance| Metric | KODK | PSNL |
|---|---|---|
| Price | $7.93 | $7.20 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $11.50 |
| AVG Volume (30 Days) | 723.0K | ★ 1.3M |
| Earning Date | 03-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 33.58 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,114,000,000.00 | $69,648,000.00 |
| Revenue This Year | N/A | $16.94 |
| Revenue Next Year | N/A | $36.58 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.93 | $2.83 |
| 52 Week High | $9.96 | $11.50 |
Technical Indicators
Market Signals| Indicator | KODK | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 62.85 | 41.03 |
| Support Level | $6.44 | $6.89 |
| Resistance Level | $9.01 | $9.64 |
| Average True Range (ATR) | 0.38 | 0.62 |
| MACD | 0.12 | -0.11 |
| Stochastic Oscillator | 82.28 | 21.91 |
Price Performance
Historical ComparisonAbout KODK Eastman Kodak Company
Eastman Kodak Co is a United States-based company. It operates through several business segments; Print, Brand, and Advanced Materials and Chemicals. The Print segment which derives the majority of revenue includes products like digital offset plate offerings and computer-to-plate imaging solutions, high-quality digital printing solutions using electrically charged toner-based technology, production press systems, consumables, inkjet components, software and services. Geographically, the company generates revenue from the United States, Canada, Europe, Middle East and Africa, Asia Pacific, and Latin America.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.